Cited by

• Computational studies for the structure and function of mRPE65.

  Guo H, Zheng C, Gaillard ER. Guo H, et al. J Theor Biol. 2007 Mar 21;245(2):312-8. doi: 10.1016/j.jtbi.2006.10.002. Epub 2006 Oct 7. J Theor Biol. 2007. PMID: 17123547 Free PMC article.
• Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial.

  Hauswirth WW, Aleman TS, Kaushal S, Cideciyan AV, Schwartz SB, Wang L, Conlon TJ, Boye SL, Flotte TR, Byrne BJ, Jacobson SG. Hauswirth WW, et al. Hum Gene Ther. 2008 Oct;19(10):979-90. doi: 10.1089/hum.2008.107. Hum Gene Ther. 2008. PMID: 18774912 Free PMC article. Clinical Trial.
• Mouse model of human RPE65 P25L hypomorph resembles wild type under normal light rearing but is fully resistant to acute light damage.

  Li Y, Yu S, Duncan T, Li Y, Liu P, Gene E, Cortes-Pena Y, Qian H, Dong L, Redmond TM. Li Y, et al. Hum Mol Genet. 2015 Aug 1;24(15):4417-28. doi: 10.1093/hmg/ddv178. Epub 2015 May 13. Hum Mol Genet. 2015. PMID: 25972377 Free PMC article.
• Rpe65 is the retinoid isomerase in bovine retinal pigment epithelium.

  Jin M, Li S, Moghrabi WN, Sun H, Travis GH. Jin M, et al. Cell. 2005 Aug 12;122(3):449-59. doi: 10.1016/j.cell.2005.06.042. Cell. 2005. PMID: 16096063 Free PMC article.
• Phenotype of three consanguineous Tunisian families with early-onset retinal degeneration caused by an R91W homozygous mutation in the RPE65 gene.

  El Matri L, Ambresin A, Schorderet DF, Kawasaki A, Seeliger MW, Wenzel A, Arsenijevic Y, Borruat FX, Munier FL. El Matri L, et al. Graefes Arch Clin Exp Ophthalmol. 2006 Sep;244(9):1104-12. doi: 10.1007/s00417-005-0096-2. Epub 2006 Feb 28. Graefes Arch Clin Exp Ophthalmol. 2006. PMID: 16518657